查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519420

2024-2032 年按服务、阶段、治疗领域（肿瘤、心血管疾病、呼吸系统疾病、中枢神经系统和精神疾病等）、最终用途行业和地区分類的临床试验用品市场报告

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System And Mental Disorders, and Others), End-Use Industry, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球临床试验用品市场规模达25亿美元。慢性病盛行率的增加、严格的监管改革、临床试验的全球化、生物技术的进步、生物相似药和孤儿药的出现，以及采用区块链和物联网等创新技术进行供应链管理，正在加速市场成长。

临床试验用品包括进行严格和受控的医学实验以评估新药、疗法或医疗设备的安全性和有效性所需的各种材料和资源。它们对于确保临床试验的顺利执行、为研究人员提供必要的工具和物质来管理治疗、收集资料和维持遵守监管标准至关重要。临床试验用品包括研究药物、安慰剂、医疗器材和生物样本。它们的用途扩展到对人类受试者测试新疗法和干预措施，以评估其治疗效果。管理良好的临床试验供应的优点包括能够维持试验盲法、确保准确的资料收集并最终推进医学知识。

全球临床试验用品市场受到慢性病盛行率不断上升和对创新疗法需求不断增长的影响。此外，旨在简化药物开发流程的监管改革和指导方针促使製药公司加强对临床试验的投资，进一步推动市场成长。与此一致的是，在追求多样化的患者群体和成本效益的运作的推动下，临床试验的全球化产生了对试验用品的更大需求，这反过来又加速了市场的成长。此外，生物技术和个人化医疗的进步正在增加临床试验的复杂性，进一步推动市场成长。除此之外，生物相似药和孤儿药的出现扩大了临床试验的范围，从而推动了市场的成长。

临床试验用品市场趋势/驱动因素：

慢性病盛行率增加

癌症、糖尿病和心血管疾病等慢性疾病的增加是全球临床试验用品市场的重要驱动力。随着人口老化和生活方式的转变，这些疾病的盛行率在全球范围内稳步上升。因此，製药公司被迫开发新药和新疗法，导致临床试验激增。这一趋势不仅刺激了对临床试验用品的需求，而且强调了有效和高效的药物开发流程来应对这些健康挑战的迫切性。此外，慢性病特定治疗领域（如肿瘤学或神经病学）对专业用品的需求增加了供应链的复杂性，使其成为市场参与者的关键关注领域。

监理改革与指导方针

世界各地卫生当局和机构发布的监管改革和指南在推动临床试验用品市场方面发挥关键作用。这些法规旨在标准化和加速药物开发过程，同时确保病人安全。製药和生物技术领域的公司必须遵守这些准则，需要严格且合规的临床试验。因此，为了满足监管要求，对高品质供应的需求不断增长。这个驱动因素不仅强调了遵守严格标准的重要性，而且还强调了高效的供应链管理和文件记录以成功应对复杂监管环境的必要性。

临床试验的全球化

临床试验的全球化是临床试验用品市场的另一个关键驱动力。製药公司越来越多地在多个国家进行试验，以接触不同的患者群体、加速招募并降低成本。这种趋势在拥有大量患者的新兴市场尤其明显。因此，对临床试验用品的需求并不局限于特定地区，而是在全球范围内扩大。这个驱动因素也强调了对强大的物流和供应链网路的需求，这些网路可以有效地支援在不同地理位置进行的试验，这些试验通常具有不同的监管要求。此外，全球化需要语言、文化和当地基础设施的适应性，这增加了供应链管理流程的复杂性。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球临床试验用品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依服务分类

  • 产品製造
    • 市场走向
    • 市场预测
  • 包装、标籤和储存
    • 市场走向
    • 市场预测
  • 物流配送
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依阶段

  • 第一阶段
    • 市场走向
    • 市场预测
  • 第二阶段
    • 市场走向
    • 市场预测
  • 第三阶段
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依治疗领域

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 心血管疾病
    • 市场走向
    • 市场预测
  • 呼吸疾病
    • 市场走向
    • 市场预测
  • 中枢神经系统和精神障碍
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依最终用途产业

  • 医疗器材业
    • 市场走向
    • 市场预测
  • 生医产业
    • 市场走向
    • 市场预测
  • 医药行业
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Almac Group Ltd.
    • Catalent Pharma Solutions Inc.
    • DHL
    • Parexel
    • Thermo Fisher Scientific Inc.
    • PCI Services
    • Sharp Clinical
    • Biocair
    • Movianto
Product Code: SR112024A2104

The global clinical trial supplies market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032. Increasing prevalence of chronic diseases, stringent regulatory reforms, the globalization of clinical trials, advancements in biotechnology, the emergence of biosimilars and orphan drugs, and the adoption of innovative technologies like blockchain and IoT for supply chain management are accelerating the market growth.

Clinical trial supplies encompass a wide range of materials and resources essential for conducting rigorous and controlled medical experiments to evaluate the safety and efficacy of new drugs, therapies, or medical devices. They are crucial in ensuring the smooth execution of clinical trials, providing researchers with the necessary tools and substances to administer treatments, collect data, and maintain compliance with regulatory standards. Clinical trial supplies consist of investigational drugs, placebos, medical devices, and biological samples. Their uses extend to the testing of novel treatments and interventions on human subjects to assess their therapeutic effects. Advantages of well-managed clinical trial supplies include the ability to maintain trial blinding, ensuring accurate data collection, and ultimately advancing medical knowledge.

The global clinical trial supplies market is influenced by the increasing prevalence of chronic diseases and the growing demand for innovative therapies. Moreover, regulatory reforms and guidelines aimed at streamlining the drug development process have prompted pharmaceutical companies to invest more in clinical trials, further propelling the market growth. In line with this, the globalization of clinical trials, driven by the pursuit of diverse patient populations and cost-effective operations, has created a greater need for trial supplies, which, in turn, is accelerating the market growth. Additionally, advancements in biotechnology and personalized medicine are increasing the complexity of clinical trials, further boosting the market growth. Apart from this, the emergence of biosimilars and orphan drugs has expanded the scope of clinical trials, which is fueling the market growth.

Clinical Trial Supplies Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is a significant driver of the global clinical trial supplies market. With an aging population and shifting lifestyle patterns, the prevalence of these conditions is steadily increasing worldwide. As a result, pharmaceutical companies are compelled to develop new drugs and therapies, necessitating an upsurge in clinical trials. This trend not only fuels the demand for clinical trial supplies but also underscores the urgency for effective and efficient drug development processes to address these health challenges. Furthermore, the need for specialized supplies for specific therapeutic areas within chronic diseases, like oncology or neurology, contributes to the complexity of the supply chain, making it a critical focus area for market players.

Regulatory reforms and guidelines

Regulatory reforms and guidelines issued by health authorities and agencies worldwide play a pivotal role in driving the clinical trial supplies market. These regulations aim to standardize and expedite the drug development process while ensuring patient safety. Companies operating in the pharmaceutical and biotechnology sectors must adhere to these guidelines, necessitating rigorous and compliant clinical trials. As a result, there is a growing demand for high-quality supplies to meet regulatory requirements. This driver not only underscores the importance of adherence to strict standards but also emphasizes the need for efficient supply chain management and documentation to navigate the complex regulatory landscape successfully.

Globalization of clinical trials

The globalization of clinical trials represents another key driver of the clinical trial supplies market. Pharmaceutical companies are increasingly conducting trials in multiple countries to access diverse patient populations, expedite recruitment, and reduce costs. This trend is especially pronounced in emerging markets with significant patient pools. Consequently, the demand for clinical trial supplies is not limited to a specific region but has expanded globally. This driver also highlights the need for robust logistics and supply chain networks that can efficiently support trials conducted in various geographical locations, often with differing regulatory requirements. Furthermore, globalization necessitates adaptability in terms of language, culture, and local infrastructure, adding complexity to the supply chain management process.

Clinical Trial Supplies Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global clinical trial supplies market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.

Breakup by Services:

Product Manufacturing

Packaging, Labeling and Storage

Logistics and Distribution

Logistics and distribution dominates the market

A detailed breakup and analysis of the market based on the services has also been provided in the report. This includes product manufacturing, packaging, labeling and storage, and logistics and distribution. According to the report, logistics and distribution represented the largest segment.

The logistics and distribution segment within the clinical trial supplies market is witnessing substantial growth due to the increasing globalization of clinical trials. As pharmaceutical companies expand their trials to diverse geographic locations, the need for efficient and reliable logistics and distribution networks becomes paramount. This includes ensuring timely delivery of supplies to various trial sites worldwide. Moreover, advancements in technology, such as the integration of blockchain and IoT, are revolutionizing supply chain management. These innovations enhance real-time tracking and monitoring of clinical trial supplies, leading to increased efficiency and reduced wastage. In line with this, the COVID-19 pandemic has underscored the importance of resilient and adaptable supply chains. Companies are now investing in robust logistics to ensure the uninterrupted flow of critical supplies, even in times of crisis. Furthermore, the emphasis on patient-centric approaches in clinical trials has led to the need for patient kits and direct-to-patient shipments. This trend requires specialized logistics solutions tailored to individual patient needs.

Breakup by Phase:

Phase I

Phase II

Phase III

Others

Phase III dominates the market

The report has provided a detailed breakup and analysis of the market based on the phase. This includes phase I, phase II, phase III, and others. According to the report, phase III represented the largest segment.

The phase III segment dominates the market as it represents the pivotal stage in evaluating a drug's efficacy and safety, making it a critical step in the regulatory approval process. This regulatory focus drives pharmaceutical companies to invest significantly in phase III trials. Moreover, as drugs progress through earlier phases, the sample size required for phase III trials increases substantially, translating into higher demand for clinical trial supplies. Additionally, phase III trials often involve a global patient population, necessitating comprehensive supply chain logistics to ensure the timely delivery of materials to diverse sites. In line with this, the increasing complexity of drug development, particularly in areas like oncology and rare diseases, necessitates larger and more complex phase III trials. This complexity includes the need for specialized supplies, patient-centric approaches, and adaptive trial designs. Furthermore, the demand for phase III trials is influenced by market dynamics, including competition and the need for differentiation in therapeutic areas. Companies seek to demonstrate superior efficacy and safety profiles, making phase III trials a pivotal stage in their product development strategies.

Breakup by Therapeutic Area:

Oncology

Cardiovascular Diseases

Respiratory Diseases

Central Nervous System (CNS) And Mental Disorders

Others

Oncology dominates the market

A detailed breakup and analysis of the market based on the therapeutic area has also been provided in the report. This includes oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. According to the report, oncology represented the largest segment.

The oncology segment is experiencing significant growth within the clinical trial supplies market, primarily driven by the escalating global incidence of cancer. With cancer being one of the leading causes of mortality worldwide, pharmaceutical companies are increasingly investing in oncology-focused clinical trials to develop novel therapies and treatments. Moreover, advances in cancer research and the identification of specific biomarkers have led to the development of targeted therapies. This trend has necessitated the need for specialized clinical trial supplies tailored to the unique requirements of oncology trials, such as precision medicine tools and specialized diagnostics. Furthermore, regulatory agencies are expediting approvals for promising oncology drugs, encouraging pharmaceutical companies to accelerate their research efforts. Consequently, there is a growing demand for clinical trial supplies to support these fast-paced trials. Besides this, collaborations between pharmaceutical firms and academic institutions or research organizations are fostering innovation in oncology research. This partnership-driven approach is increasing the scope and complexity of clinical trials, thereby boosting the demand for clinical trial supplies.

Breakup by End-Use Industry:

Medical Device Industry

Biopharmaceuticals Industry

Pharmaceuticals Industry

Others

Pharmaceuticals industry hold the largest share in the market

A detailed breakup and analysis of the market based on the end-use industry has also been provided in the report. This includes medical device industry, biopharmaceuticals industry, pharmaceuticals industry, and others. According to the report, pharmaceuticals industry represented the largest segment.

The pharmaceuticals segment is experiencing substantial growth driven by the increasing global burden of chronic diseases, including cancer, cardiovascular ailments, and diabetes, which has led to a heightened demand for innovative drugs and therapies. Moreover, regulatory reforms and evolving healthcare policies are shaping the industry landscape. Stringent regulations and guidelines, particularly in developed markets, necessitate compliance and adherence to safety standards. This environment promotes innovation and the development of high-quality pharmaceutical products. Furthermore, advancements in biotechnology and genomics have ushered in an era of precision medicine. Tailoring treatments to individual patient profiles is becoming more common, driving research and development efforts in the pharmaceutical sector. Apart from this, the emergence of biosimilars and orphan drugs is expanding the pharmaceutical market's scope. Biosimilars offer cost-effective alternatives to biologics, while orphan drugs target rare diseases, presenting lucrative opportunities for pharmaceutical companies.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical trial supplies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest segment.

North America's clinical trial supplies market is witnessing substantial growth, fueled by the region's well-established pharmaceutical and biotechnology sector, coupled with a robust healthcare infrastructure, creates a conducive environment for clinical trials. Moreover, regulatory agencies like the FDA in the United States have streamlined approval processes, encouraging pharmaceutical companies to conduct trials in the region. In line with this, North America's diverse patient populations and access to specialized healthcare facilities make it an attractive destination for clinical trials across various therapeutic areas. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and cancer, drives the demand for clinical trials to develop innovative treatments. Additionally, the emergence of cutting-edge technologies like genomics and precision medicine is propelling North America's position as a hub for advanced clinical research. The pandemic's impact has also accelerated the adoption of virtual and decentralized trials in the region, further contributing to market growth.

Competitive Landscape:

The competitive landscape of the clinical trial supplies market is characterized by a dynamic interplay of various stakeholders, each contributing to the industry's growth and evolution. Service providers in this sector offer a wide range of solutions, including clinical packaging, labeling, distribution, and logistics services, making it a highly specialized and competitive field. Key players in the market differentiate themselves through their global reach, technological capabilities, regulatory compliance, and ability to cater to diverse therapeutic areas. These companies often form strategic partnerships with pharmaceutical and biotechnology firms to provide end-to-end solutions for clinical trials. In addition to established companies, the market also sees the emergence of niche players focusing on specific areas such as direct-to-patient services, temperature-sensitive logistics, and innovative supply chain technologies. These specialized firms cater to the evolving needs of the industry, offering unique solutions to enhance efficiency and cost-effectiveness. Moreover, the market's competitive landscape is influenced by regulatory changes, as compliance with stringent standards is imperative. This factor underscores the importance of choosing suppliers with a proven track record in maintaining the highest quality and compliance levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Almac Group Ltd.

Catalent Pharma Solutions Inc.

DHL

Parexel

Thermo Fisher Scientific Inc.

PCI Services

Sharp Clinical

Biocair

Movianto

Recent Developments:

In September 2023, Parexel and Partex have inked a deal aiming to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for biopharmaceutical customers worldwide and de-risk the assets in their portfolios.

In September 2023, DHL Express commenced the full-fledged operation of Incheon Gateway after it invested €131 million to expand the Gateway in 2019. The investment is DHL Express's largest in South Korea to date, making Incheon Gateway the largest gateway in the Asia Pacific.

In June 2021, Catalent announced that it has expanded its integrated development, manufacturing and supply solution, OneBio(R) Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

Key Questions Answered in This Report:

  • How has the global clinical trial supplies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global clinical trial supplies market?
  • What is the impact of each driver, restraint, and opportunity on the global clinical trial supplies market?
  • What are the key regional markets?
  • Which countries represent the most attractive clinical trial supplies market?
  • What is the breakup of the market based on the services?
  • Which are the most attractive services in the clinical trial supplies market?
  • What is the breakup of the market based on the phase?
  • Which is the most attractive phase in the clinical trial supplies market?
  • What is the breakup of the market based on the therapeutic area?
  • Which is the most attractive therapeutic area in the clinical trial supplies market?
  • What is the breakup of the market based on end-use industry?
  • Which is the most attractive end-use industry in the clinical trial supplies market?
  • What is the competitive structure of the global clinical trial supplies market?
  • Who are the key players/companies in the global clinical trial supplies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Trial Supplies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Services

  • 6.1 Product Manufacturing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Packaging, Labeling and Storage
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Logistics and Distribution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Phase

  • 7.1 Phase I
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Phase II
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phase III
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Respiratory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 CNS and Mental Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use Industry

  • 9.1 Medical Device Industry
    • 9.1.1 Market Trends
    • 9.1.3 Market Forecast
  • 9.2 Biopharmaceuticals Industry
    • 9.2.1 Market Trends
    • 9.2.3 Market Forecast
  • 9.3 Pharmaceuticals Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.3 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Almac Group Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Catalent Pharma Solutions Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 DHL
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Parexel
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Thermo Fisher Scientific Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PCI Services
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Sharp Clinical
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Biocair
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Movianto
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Clinical Trial Supplies Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Supplies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Trial Supplies Market: Breakup by Services (in %), 2023
  • Figure 4: Global: Clinical Trial Supplies Market: Breakup by Phase (in %), 2023
  • Figure 5: Global: Clinical Trial Supplies Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 6: Global: Clinical Trial Supplies Market: Breakup by End-Use Industry (in %), 2023
  • Figure 7: Global: Clinical Trial Supplies Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Trial Supplies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Clinical Trial Supplies (Product Manufacturing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Clinical Trial Supplies (Product Manufacturing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Clinical Trial Supplies (Logistics and Distribution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Clinical Trial Supplies (Logistics and Distribution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Clinical Trial Supplies (Phase I) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Clinical Trial Supplies (Phase I) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Clinical Trial Supplies (Phase II) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Clinical Trial Supplies (Phase II) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Clinical Trial Supplies (Phase III) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Clinical Trial Supplies (Phase III) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Clinical Trial Supplies (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Clinical Trial Supplies (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Clinical Trial Supplies (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Clinical Trial Supplies (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Clinical Trial Supplies (Medical Devices Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Clinical Trial Supplies (Medical Devices Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia Pacific: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia Pacific: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Clinical Trial Supplies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Clinical Trial Supplies Industry: SWOT Analysis
  • Figure 90: Global: Clinical Trial Supplies Industry: Value Chain Analysis
  • Figure 91: Global: Clinical Trial Supplies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Supplies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clinical Trial Supplies Market Forecast: Breakup by Services (in Million US$), 2024-2032
  • Table 3: Global: Clinical Trial Supplies Market Forecast: Breakup by Phase (in Million US$), 2024-2032
  • Table 4: Global: Clinical Trial Supplies Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 5: Global: Clinical Trial Supplies Market Forecast: Breakup by End-Use Industry (in Million US$), 2024-2032
  • Table 6: Global: Clinical Trial Supplies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Clinical Trial Supplies Market: Competitive Structure
  • Table 8: Global: Clinical Trial Supplies Market: Key Players